Quince Therapeutics Inc (QNCX)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -6.32M | -12.96M | -5.58M | -6.16M | -9.92M | -11.22M | -28.19M | -5.86M |
税引前収入 | -5.53M | -12.5M | -4.89M | -5.35M | -8.84M | -11.12M | -27.69M | -5.48M |
純利益 | -5.53M | -12.25M | -4.89M | -5.35M | -8.89M | -11.15M | -27.73M | -5.49M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -6.07M | -13.2M | -5.69M | -6.31M | -9.86M | -11.62M | -28.1M | -5.71M |
EBITDA | -6.28M | -7.04M | -5.58M | -6.16M | -9.62M | -11.18M | -11.02M | -5.78M |
年末 2023年12月31日 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -10.37M | -12.12M | -39.17M | -78.89M | -90.32M | -52.02M | -34.62M |
税引前収入 | -12.24M | -12.48M | -36.98M | -76.85M | -89.95M | -51.94M | -31.58M |
純利益 | -12.24M | -12.48M | -36.98M | -76.85M | -89.95M | -51.66M | -31.39M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -3.64 | -3.657 | -1.376 | -2.601 | -2.991 | -1.43 | -0.732 |
EBIT | -10.37M | -12.12M | -39.17M | -78.89M | -90.57M | -53.01M | -35.06M |
EBITDA | -10.33M | -12.07M | -38.98M | -78.56M | -89.97M | -50.99M | -28.4M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約